MP
Mangrove Partners Portfolio holdings
AUM
$931M
This Quarter Return
-27.36%
1 Year Return
+45.39%
3 Year Return
+156.75%
5 Year Return
+144.79%
10 Year Return
+262.25%
AUM
$710M
AUM Growth
+$710M
(+6.9%)
Cap. Flow
+$324M
Cap. Flow
% of AUM
45.65%
Top 10 Holdings %
Top 10 Hldgs %
67.4%
Holding
85
New
11
Increased
15
Reduced
12
Closed
10
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
$224M |
| 2 |
PG&E
PCG
|
$29.1M |
| 3 |
Super Micro Computer
SMCI
|
$28.2M |
| 4 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$23.6M |
| 5 |
TG Therapeutics
TGTX
|
$12.2M |
Top Sells
| 1 |
NIHD
NII Holdings, Inc. Common Stock
NIHD
|
$17.8M |
| 2 |
Iovance Biotherapeutics
IOVA
|
$8.84M |
| 3 |
FOMX
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
|
$5.93M |
| 4 |
Gyre Therapeutics
GYRE
|
$4.65M |
| 5 |
DERM
Dermira, Inc.
DERM
|
$3.36M |
Sector Composition
| 1 | Healthcare | 17.07% |
| 2 | Energy | 8.29% |
| 3 | Communication Services | 7.68% |
| 4 | Materials | 6.03% |
| 5 | Industrials | 4.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iShares Russell 2000 ETF
IWM
$67B
| $224M | 30.96% | +1,961,000 | New | +$224M |
|
2
EchoStar
SATS
$17.8B
| $52.8M | 7.28% | 1,651,083 +125,474 | +8% | +$4.01M |
|
|
3
PG&E
PCG
$33.6B
| $32.8M | 4.52% | 3,644,586 +3,240,622 | +802% | +$29.1M |
|
|
4
Super Micro Computer
SMCI
$24.7B
| $28.2M | 3.9% | +1,326,986 | New | +$28.2M |
|
|
AAMI
5
Acadian Asset Management Inc.
AAMI
$1.83B
| $27.1M | 3.74% | 4,241,119 +60,446 | +1% | +$386K |
|
|
6
Iovance Biotherapeutics
IOVA
$807M
| $25.8M | 3.56% | 863,377 -295,239 | -25% | -$8.84M |
|
|
CCXI
7
DELISTED
ChemoCentryx, Inc.
CCXI
| $23.6M | 3.25% | +586,523 | New | +$23.6M |
|
8
Civitas Resources
CIVI
$3.41B
| $23.2M | 3.2% | 2,060,700 | – | – |
|
9
SunCoke Energy
SXC
$654M
| $22.3M | 3.08% | 5,791,492 +682,400 | +13% | +$2.63M |
|
|
DSSI
10
DELISTED
Diamond S Shipping Inc. Common Shares
DSSI
| $18.6M | 2.57% | 1,576,648 +1,004,412 | +176% | +$11.9M |
|
11
International Seaways
INSW
$2.24B
| $18M | 2.49% | 754,704 -90,271 | -11% | -$2.16M |
|
12
ANI Pharmaceuticals
ANIP
$2.03B
| $17.4M | 2.39% | 426,162 +99,384 | +30% | +$4.05M |
|
13
Green Plains
GPRE
$728M
| $17M | 2.35% | 3,513,739 -81,718 | -2% | -$396K |
|
14
Catalyst Pharmaceutical
CPRX
$2.52B
| $16.8M | 2.31% | 4,355,416 +2,807,100 | +181% | +$10.8M |
|
|
AT
15
DELISTED
Atlantic Power Corporation
AT
| $16M | 2.21% | 7,484,189 -270,789 | -3% | -$579K |
|
|
CAI
16
DELISTED
CAI International, Inc.
CAI
| $14.1M | 1.94% | 996,897 -104,276 | -9% | -$1.47M |
|
17
Cartesian Therapeutics
RNAC
$261M
| $13.4M | 1.84% | 5,548,857 +294,341 | +6% | +$709K |
|
|
18
TG Therapeutics
TGTX
$4.65B
| $12.2M | 1.69% | +1,241,706 | New | +$12.2M |
|
19
Genco Shipping & Trading
GNK
$723M
| $10.1M | 1.4% | 1,579,322 -87,500 | -5% | -$562K |
|
|
STON
20
DELISTED
StoneMor Inc.
STON
| $10.1M | 1.39% | 9,711,014 -583,818 | -6% | -$607K |
|
|
PDCE
21
DELISTED
PDC Energy, Inc.
PDCE
| $9.67M | 1.33% | 1,557,612 -320,408 | -17% | -$1.99M |
|
22
Immunovant
IMVT
$2.56B
| $8.9M | 1.23% | 571,942 +471,942 | +472% | +$7.35M |
|
23
Cue Biopharma
CUE
$60M
| $8.53M | 1.18% | 601,398 | – | – |
|
|
BMY.RT
24
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $6.96M | 0.96% | +1,830,600 | New | +$6.96M |
|
|
FLY
25
DELISTED
Fly Leasing Limited
FLY
| $5.77M | 0.8% | 819,198 +68,260 | +9% | +$481K |
|